CoChat

A Prospective Multicenter Clinical Performance Evaluation of the C-CGM System

Open access
Rebec, Mihailo, Cai, Kevin, Dutt-Ballerstadt, Ralph, Anderson, Ellen · 2022 · Journal of Diabetes Science and Technology

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background: Continuous glucose monitors (CGMs) have had a significant impact on the management of diabetes mellitus. We present the results of a multinational evaluation of the Cascade CGM (“C-CGM”) over 14 days of in-clinic and home use. Method: Each of the 57 enrolled type 1 diabetes mellitus and type 2 diabetes mellitus subjects wore 2 C-CGMs on the abdomen for 14 days. One part of the evaluation was the performance versus reference glucose values generated for 12 -hour in-clinic sessions on days 1, 4, 7, 10, and 14. Glucose blood samples were drawn every 15 minutes and analyzed with the Yellow Spring Instruments (YSI) 2300 glucose analyzer. The performance assessment on in-clinic days was based on paired YSI/CGM data points and on home-use days was based on paired fingerstick BGM (blood glucose monitoring)/CGM data points. Results: A total of 17 823 CGM/YSI data points during in-clinic use was analyzed. The mean absolute relative difference for glucose values between 100 and 400 mg/dL (MARD) and mean absolute difference for values between 40 and 100 mg/dL (MAD) were 11.5% and 15.1 mg/dL, respectively. The system accuracy during home use was 12.7% and 15 mg/dL for MARD and MAD, respectively. There were no serious adverse events or infectious complications reported. A modified algorithm “Hybrid Algorithm” was used in a prospective analysis of the in-clinic data, resulting in a MARD of 9.9% and MAD of 14.5 mg/dL. Conclusions: The performance of the C-CGM device over 14 days meets the safety and efficacy standards of CGM systems for managing blood glucose levels in people with diabetes. This was further confirmed when the C-CGM system was given approval for CE Mark in October 2019.

Overview

Integrity signals

Registry

Crossref · 10.1177/1932296820964574

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 5

  1. IDF Diabetes Atlas Eighth Edition 2017. Available at: https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.
  2. Christiansen MP, 2019, DiabetesTechnolTher, 21, 231
  3. Rebec M, 2018, J Diabetes Sci Technol, 12, 426, 10.1177/1932296818761742 · DOI
  4. Rebec M, 2018, Diabetologia, 61, 1
  5. Draize JH, 1944, J Pharmacol Exp Ther, 82, 377

Cited by

See all 11

Metadata

Authors
Rebec, M., Cai, K., Dutt-Ballerstadt, R., & Anderson, E.
Affiliations
  • Wilson Community College (US)
  • WaveForm Diabetes, Inc., Salem, NH, USA
  • WaveForm Diabetes, Inc., Wilsonville, OR, USA
Corresponding author
Rebec, Mihailo
Venue
Journal of Diabetes Science and Technology
Published
2020-10-21
Volume
16
Issue
2
Pages
390-396
ISSN
1932-2968 (ISSN-L)
OpenAlex
W3093629784
Cited by
11
References
11
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 2
FWCI
0.94
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
continuous glucose monitoring, type 1 diabetes, type 2 diabetes, device accuracy, mean absolute relative difference, home blood glucose monitoring, hybrid algorithm
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Blood Glucose Self-Monitoring, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Prospective Multicenter Clinical Performance Evaluation of the C-CGM System. https://app.cochat.ai/papers/10.1177/1932296820964574
The paper
Rebec, M., Cai, K., Dutt-Ballerstadt, R., & Anderson, E. (2022). A Prospective Multicenter Clinical Performance Evaluation of the C-CGM System. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296820964574

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.